J. Dudley

发表

Deactivated CRISPR Associated Protein 9 for Minor-Allele Enrichment in Cell-Free DNA.

J. Chabon, S. Gambhir, M. Diehn, 2018, Clinical chemistry.

Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)

Tej D Azad, Tej D. Azad, Kevin Chen, 2019, Molecular Diagnosis & Therapy.

Challenges posed to pathologists in the detection of KRAS mutations in colorectal cancers.

Lisa M Haley, J. Eshleman, Ming-Tseh Lin, 2015, Archives of pathology & laboratory medicine.

Cytomorphologic characteristics of next-generation sequencing-positive bile duct brushing specimens.

A. Iafrate, L. Le, J. Dudley, 2020, Journal of the American Society of Cytopathology.

Preoperative characteristics and cytological features of 136 histologically confirmed pancreatic mucinous cystic neoplasms

M. Mino‐Kenudson, J. Dudley, W. Brugge, 2017, Cancer cytopathology.

Clinicopathological characteristics of invasive gastric Helicobacter pylori.

Jeanne Shen, M. Selig, J. Dudley, 2017, Human pathology.

Next‐generation sequencing adds value to the preoperative diagnosis of pancreatic cysts

A. Iafrate, L. Le, J. Dudley, 2017, Cancer cytopathology.

Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid

Christopher M. Jackson, J. Ptak, K. Kinzler, 2022, medRxiv.

A Novel Tandem Duplication Assay to Detect Minimal Residual Disease in FLT3/ITD AML

Ming-Tseh Lin, J. Dudley, M. Levis, 2015, Molecular Diagnosis & Therapy.

Lymph node metastases of melanoma: challenges for BRAF mutation detection.

J. Eshleman, Ming-Tseh Lin, J. Dudley, 2015, Human pathology.

Microsatellite Instability as a Biomarker for PD-1 Blockade

James R. Eshleman, Ming-Tseh Lin, J. Eshleman, 2016, Clinical Cancer Research.

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.

Ash A. Alizadeh, Aaron M. Newman, R. West, 2017, Cancer Discovery.

Non-p.V600E BRAF Mutations Are Common Using a More Sensitive and Broad Detection Tool.

J. Eshleman, Ming-Tseh Lin, P. Illei, 2015, American journal of clinical pathology.

Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers

Lisa M Haley, J. Eshleman, Ming-Tseh Lin, 2015, Modern Pathology.

Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA.

Ash A. Alizadeh, Simon B. Chen, Helio A. Costa, 2018, Cancer discovery.

Next-Generation Sequencing and Fluorescence in Situ Hybridization Have Comparable Performance Characteristics in the Analysis of Pancreaticobiliary Brushings for Malignancy.

Thomas O. McDonald, Julie M. Batten, A. Iafrate, 2016, The Journal of molecular diagnostics : JMD.

Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.

A. Iafrate, M. Mino‐Kenudson, D. Dias-Santagata, 2016, Gastrointestinal endoscopy.

Tumor Cellularity as a Quality Assurance Measure for Accurate Clinical Detection of BRAF Mutations in Melanoma

J. Taube, J. Eshleman, Ming-Tseh Lin, 2014, Molecular Diagnosis & Therapy.

Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions

Johannes G. Reiter, L. Wood, R. Karchin, 2020, Gut.

Detection of rare mutations, copy number alterations, and methylation in the same template DNA molecules.

J. Ptak, K. Kinzler, C. Bettegowda, 2023, Proceedings of the National Academy of Sciences of the United States of America.

Tumor Cellularity as a Quality Assurance Measure for Accurate Clinical Detection of BRAF Mutations in Melanoma

J. Taube, J. Eshleman, Ming-Tseh Lin, 2014, Molecular Diagnosis & Therapy.

Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands

J. Ptak, K. Kinzler, B. Vogelstein, 2021, Nature Biotechnology.

Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)

A. Chaudhuri, J. Dudley, R. Chin, 2019, Molecular Diagnosis & Therapy.

Colorectal cancer in patients of advanced age is associated with increased incidence of BRAF p.V600E mutation and mismatch repair deficiency

J. Eshleman, Ming-Tseh Lin, E. Jaffee, 2023, Frontiers in Oncology.

Detection and Diagnostic Utilization of Cellular and Cell-Free Tumor DNA.

M. Diehn, J. Dudley, 2020, Annual Review of Pathology.

Analysis of circulating tumor DNA in localized lung cancer for detection of molecular residual disease and personalization of adjuvant strategies.

Ash A. Alizadeh, Aaron M. Newman, A. Newman, 2017 .

A Novel Tandem Duplication Assay to Detect Minimal Residual Disease in FLT3/ITD AML

Ming-Tseh Lin, J. Dudley, M. Levis, 2015, Molecular Diagnosis & Therapy.

Early detection of endometrial cancer.

J. Dudley, Aric J. Fader, Jiaxin Ge, 2023, Gynecologic Oncology.

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.

Ash A. Alizadeh, Aaron M. Newman, Justin N. Carter, 2017, Cancer discovery.